Skip to content

Opening book details…

About this Medicine article

Cost-effectiveness of Niraparib, Rucaparib, and Olaparib for Treatment of Platinum-resistant, Recurrent Ovarian Carcinoma by Wolford, Juliet E.; Bai, Jiaru; Moore, Kathleen N.; Kristeleit, Rebecca; Monk, Bradley J.; Tewari, Krishnansu S. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Wolford, Juliet E.; Bai, Jiaru; Moore, Kathleen N.; Kristeleit, Rebecca; Monk, Bradley J.; Tewari, Krishnansu S.
Publisher
Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 0090-8258)
Published
2020
Field
Medicine (Health Sciences)

More by Wolford, Juliet E.; Bai, Jiaru; Moore, Kathleen N.; Kristeleit, Rebecca; Monk, Bradley J.; Tewari, Krishnansu S.

Browse all works by Wolford, Juliet E.; Bai, Jiaru; Moore, Kathleen N.; Kristeleit, Rebecca; Monk, Bradley J.; Tewari, Krishnansu S.